HLA-DRB1 and myeloid sarcoma: With respect to genetic risk, African Americans with the HLA-DRB*1501 risk allele are three times more likely to develop MS than those with the African haplotype (70) and Japanese MS patients with the HLA-DRB*1501 risk allele are more likely to have intracortical lesions associated with more severe disease (46).